Together, these results suggest that as in the case of MEK1/2 inhibition [33], [34], increased Bim/Mcl-1 association is likely to play a pro-apoptotic role in the ability of this regimen to circumvent Mcl-1-dependent drug resistance in MM cells. The gene discussed is MCL1; the disease is Miyoshi myopathy.